Emerging opportunities to target inflammation: myocardial infarction and type 2 diabetes
{{output}}
After myocardial infarction (MI), patients with type 2 diabetes have an increased rate of adverse outcomes, compared to patients without. Diabetes confers a 1.5-2-fold increase in early mortality and, importantly, this discrepancy has been consistent over rece... ...